Form 8-K - Current report:
SEC Accession No. 0001628280-17-009553
Filing Date
2017-09-29
Accepted
2017-09-29 17:07:21
Documents
4
Period of Report
2017-09-29
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K - TOTECT LAUNCH a8k-totectlaunch.htm 8-K 32167
2 EXHIBIT 99.1 - TOTECT LAUNCH pressrelease-totectlaunch.htm EX-99.1 42482
3 clinigennew.jpg GRAPHIC 4643
4 cumberlanda07.gif GRAPHIC 10657
  Complete submission text file 0001628280-17-009553.txt   96970
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 171112244
SIC: 2834 Pharmaceutical Preparations